lobbying_activities: 1594182

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1594182	7406df1a-87e2-46c2-95e8-7000e59e7513	Q3	CAPITOL HILL CONSULTING GROUP	72053	PROFESSIONAL COMPOUNDING CENTERS OF AMERICA	2014	third_quarter	PHA	Pharmaceutical Compounding and Accountability Act (S.959) The Compound Clarity Act (H.R.3089) The Drug Quality and Security Act (H.R.3204) Issues related to implementation of the Compounding Quality Act	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2014-10-17T15:13:24.520000-04:00